References
- Koch G. Acute haemodynamic effects of an alpha and beta receptor blocking agent (AH 5158) on systemic and pulmonary circulation at rest and during exercise in hypertensive patients. Am Heart J 1977; 93: 585
- Lunell N O, Nylund L, Levander R, Sarby B. Acute effect of an antihypertensive drug, labetalol on uteropla cental blood flow. Br J Obstet Gynaecol 1982; 89: 640–3
- Redman C WG. A controlled trial of the treatment of hypertension in pregnancy: labetalol compared with methyldopa. Proc. Symp. Royal Coll. Physicians (London). Excerpta Med, Amsterdam 1982; 101–10
- Walker J J, Crooks A, Erwin L, Calder A A. A controlled trial of the treatment of hypertension in pregnancy: labetalol compared with methyldopa. Proc. Symp. Royal Coll. Physicians (London). Excerpta Med, Amsterdam 1982; 148–60
- Lunell N O, Hjemdahl P, Fredholm B F, Nisell H, Persson B, Wager J. Circulatory and metabolic effects of a combined alpha-and beta-adrenoceptor blocker (labetalol) in hypertension of pregnancy. Br J Clin Pharmacol 1981; 12: 345–8
- Andersson K E. Pharmacological inhibition of uterine activity. Acta Obstet Gynecol Scand 1975, Suppl.l08: 17–23
- Carey B, Whalley E T. Beta-adrenoceptor agonist activity of labetalol on the isolated uterus of the rat. Br J Pharmacol 1979; 67: 13–5
- Bilski A J, Halliday S E, Fitzgerald J D, Wale J L. Pharmacology of a beta-2-selective adrenoceptor antagonist (1CI 118, 551). J Cardiovasc Pharmacol 1983; 5: 430–7
- Saameli K. Effects on the uterus. Ergot alkaloids and related compounds, B. Berde, H O Schild. Springer Verlag, Berlin 1978; 233–319
- Berg G, Andersson R C, Rydén G. Effect of selective beta-adrenergic agonists on spontaneous contractions, cAMP levels and phosphodiesterase activity in myo-metrial strips from pregnant women treated with terbu-taline. Gynecol Obstet Invest 1982; 14: 56–64
- Wikland M, Lindblom B, Wilhelmsson L, Wiqvist N. Oxytocin, prostaglandins and contractility of the human uterus at term pregnancy. Acta Obstet Gynecol Scand 1982; 61: 467–72
- Thulesius O, Gjöres J E, Berlin E. Alpha-and beta-adrenoceptor blockade by labetalol in human isolated arteries and veins. Br J Clin Pharmacol 1980; 9: 621–3
- Thorbert G, Aim P, Björkund A, Owman C, Sjöberg N O. Adrenergic innervation of the human uterus. Am J Obstet Gynecol 1979; 135: 223–6
- Richards D A, Riley A I. A controlled trial of the treatment of hypertension in pregnancy: labetalol compared with methyldopa. Proc. Symp. Royal Coll. Physicians (London). Excerpta Med, Amsterdam 1982; 10–5
- Brittain R T, Drew G M, Levy G P. The alpha-and beta-adrenoceptor blocking potencies of labetalol and its individual stereoisomers in anaesthetized dogs and isolated tissues. Br J Pharmacol 1982; 77: 105–14